Founded in 2011, Jumpstart Ventures is a venture capital firm based in Cleveland, Ohio. It partners with entrepreneurs to invest in companies that aim to solve complex problems through intelligent innovation and ambitious solutions, focusing on sectors such as enterprise software, data analytics, biomedical tech, devices, insurtech, fintech, and life sciences.
Invirsa develops therapeutic agents that enhance immunity and promote healing. Its lead compound, INV-102, reduces cellular injury caused by infections like adenovirus, stimulates immune response, and accelerates wound repair. Invirsa focuses on treating conditions such as keratoconjunctivitis and upper respiratory tract infections.
Axuall
Series B in 2023
Axuall provides a digital platform for verifying identities, credentials, and authenticity across various sectors. It specializes in healthcare workforce intelligence, enabling healthcare systems, staffing firms, and telehealth providers to streamline onboarding processes and gain valuable data insights for network planning and analytics.
Presta
Pre Seed Round in 2023
Presta provides digital lending infrastructure for the banking industry through a platform that integrates lending processes to speed loan applications and decisions, helping banks, community development financial institutions, and other lenders reach more businesses with reduced costs and risk and higher originations. The company was founded in 2022 and is headquartered in Cleveland, Ohio.
Centerline Biomedical
Series B in 2022
Centerline Biomedical, Inc. is a Cleveland, Ohio-based company founded in 2014 that specializes in developing advanced surgical navigation technologies. The company focuses on an Intra-Operative Positioning System, which utilizes non-x-ray based three-dimensional GPS technology to enhance the precision of endovascular procedures and minimize radiation exposure for both patients and medical staff. Centerline's innovative system aids surgeons in navigating complex three-dimensional vascular anatomy, thereby improving surgical outcomes in interventional vascular procedures. The technology is rooted in advancements made at the Cleveland Clinic, reflecting a commitment to enhancing the safety and effectiveness of minimally invasive surgeries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.